满￥6666，赠豪华版黑神话悟空
Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
生化试剂
/
糖类及其衍生物
膜转运蛋白
/
SGLT
糖醇
/ Dapagliflozin

达格列净 /Dapagliflozin 98%+

货号：A120381 同义名： 达格列嗪 / BMS-512148 Ambeed 开学季，买赠积分，赢豪礼

Dapagliflozin（BMS-512148）是一种治疗糖尿病的新药，是一种竞争性钠/葡萄糖协同转运蛋白2（SGLT2）抑制剂，导致尿中葡萄糖排泄。Dapagliflozin诱导HIF1表达并减少肾缺血再灌注损伤。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Dapagliflozin 化学结构 CAS号：461432-26-8
Dapagliflozin 化学结构
CAS号：461432-26-8
Dapagliflozin 3D分子结构
CAS号：461432-26-8
Dapagliflozin 化学结构 CAS号：461432-26-8
Dapagliflozin 3D分子结构 CAS号：461432-26-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Dapagliflozin 纯度/质量文件 产品仅供科研

货号：A120381 标准纯度： 98%+
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Cell,2024. Ambeed. [ A125712 ]
• Cancer Discov., 2024. Ambeed. [ A285925 ]
• JMC, 2024. Ambeed. [ A288696 ]
• JMC, 2024. Ambeed. [ A524399 , A633512 , A144280 , A174613 ]
• EJNMMI Radiopharm. Chem., 2024, 9, 61. Ambeed. [ A1257961 , A622068 ]
更多 >
产品名称 SGLT1 ↓ SGLT2 ↓ 其他靶点 纯度
Phloretin ✔ 99%+
Canagliflozin +++

mSGLT2, IC50: 2 nM

hSGLT2, IC50: 3.7 nM

 		95%
Empagliflozin ++

SGLT2, IC50: 3.1 nM

 		98%
Dapagliflozin ++++

hSGLT2, EC50: 1.1 nM

 		98%+
Tofogliflozin (hydrate) +++

hSGLT2, IC50: 2.9 nM

 		99%+
Sotagliflozin +

SGLT1, IC50: 36 nM

 		++++

SGLT2, IC50: 1.8 nM

 		99%+
Ipragliflozin ++

hSGLT2, IC50: 7.4 nM

 		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Dapagliflozin 生物活性

靶点

  • SGLT2

    hSGLT2, EC50:1.1 nM
描述 The sodium-dependent glucose transport (SGLT) proteins belong to the sodium glucose cotransporter family. Sodium-dependent glucose transport 2 (SGLT2) is a high-capacity, low-affinity transporter that is expressed mainly in the kidney. It has a Na(+) to glucose coupling ratio of 1:1. It is estimated that 90% of renal glucose reabsorption is facilitated by SGLT2 residing on the surface of the epithelial cells lining the S1 segment of the proximal tubule. Dapagliflozin is a potent and selective SGLT2 inhibitor. In an experiment system of Chinese hamster ovary cells stably expressing human SGLT2 and SGLT1, data yielded by monitoring inhibition of AMG showed that the EC50 of dapagliflozin for human SGLT2 inhibition was 1.1 nM, while that for human SGLT1 was 1390 nM[7]. In acute normal and diabetic rat studies, SD or ZDF rats were dosed orally with single doses of dapagliflozin at 0.01 mg/kg, 0.1 mg.kg, 1 mg/kg or 10 mg/kg. In normal rats， the results were that dapagliflozin caused significant dose-dependent glucosuria and increase in urine volume, with 1 mg/kg producing a 400-fold increase in urine glucose and a threefold increase in urine volume versus vehicle over 24 h post-dose. Dapagliflozin administration was also associated with a reduction in glucose area under the curve over 1 h post-dose at 1 and 10 mg/kg doses in the glucose tolerance test in normal rats. In ZDF rats, dapagliflozin dose-dependently increased urine glucose and urine volume excretion at 6 h post-dose [8]. In another study, dapagliflozin was administrated at the dose of 0.5 mg/kg orally once daily for 15 days. When measured 24 h after the final dose on day 15, ZDF rats treated with dapagliflozin displayed a 53% decrease in 18-h FPG level compared with vehicle-treated rats[8].

Dapagliflozin 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
CHO cells Function assay 2 h Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]alpha-methyl-D-glucopyranoside uptake after 2 hrs by liquid scintillation counting, IC50=0.00049 μM 20434909
CHOK1 cells Function assay 3 h Inhibition of human SGLT2 expressed in CHOK1 cells assessed as inhibition of [14C]-AMG uptake after 3 hrs by microbeta scintillation counting analysis, IC50=0.001 μM 24842618
COS-7 cells Function assay 2 h Inhibition of human SGLT1 transfected in COS-7 cells assessed as AMG uptake after 2 hrs by scintillation counting, IC50=0.89 μM 19896374
HEK293.ETN cells Function assay 1.5 h Inhibition of human SGLT2 transfected in HEK293.ETN cells assessed as AMG uptake after 1.5 hrs by scintillation counting, IC50=0.0067 μM 19896374

Dapagliflozin 动物研究

Dose Rat: 0.1 mg/kg - 1 mg/kg[3] (p.o.); 10 mg/kg[4] (i.p.), 75 mg/kg, 150 mg/kg[5] (i.p.)
Administration p.o., i.p.
Pharmacokinetics
Animal Rats[6]
Dose 1 mg/kg
Administration p.o.
F 0.84
T1/2 4.6 h
Tmax 1.7 h
CL 4.8 ml/min/kg
Cmax 0.6 µg/mL
Vss 1.6 L/kg

Dapagliflozin 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02096705 Diabetes Phase 3 Completed - -
NCT03565458 Type 2 Diabetes Mellitus Phase 1 Active, not recruiting December 22, 2018 Korea, Republic of ... 展开 >> LG chem Seoul, Gangseo-Gu, Korea, Republic of, 07795 收起 <<
NCT02096705 - Completed - -

Dapagliflozin 参考文献

[1]Han S, Hagan DL, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes. 2008 Jun;57(6):1723-9.

[2]Perry RJ, Rabin-Court A, et al. Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats. Nat Commun. 2019 Feb 1;10(1):548.

[3]Erdogan MA, Yusuf D, et al. Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy. BMC Neurol. 2018 Jun 7;18(1):81.

[4]Meng W, Ellsworth BA, et al. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem. 2008 Mar 13;51(5):1145-9.

[5]Meng W, Ellsworth BA, Nirschl AA, McCann PJ, Patel M, Girotra RN, Wu G, Sher PM, Morrison EP, Biller SA, Zahler R, Deshpande PP, Pullockaran A, Hagan DL, Morgan N, Taylor JR, Obermeier MT, Humphreys WG, Khanna A, Discenza L, Robertson JG, Wang A, Han S, Wetterau JR, Janovitz EB, Flint OP, Whaley JM, Washburn WN. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem. 2008 Mar 13;51(5):1145-9. doi: 10.1021/jm701272q. Epub 2008 Feb 9. PMID: 18260618.

[6]Han S, Hagan DL, Taylor JR, Xin L, Meng W, Biller SA, Wetterau JR, Washburn WN, Whaley JM. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes. 2008 Jun;57(6):1723-9. doi: 10.2337/db07-1472. Epub 2008 Mar 20. PMID: 18356408.

Dapagliflozin 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.45mL

0.49mL

0.24mL

12.23mL

2.45mL

1.22mL

24.46mL

4.89mL

2.45mL

Dapagliflozin 技术信息

CAS号461432-26-8
分子式C21H25ClO6
分子量 408.87
别名 达格列嗪 ;BMS-512148
运输蓝冰
存储条件

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月
溶解度

DMSO: 105 mg/mL(256.81 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H2O: 50 mg/mL(122.29 mM)，配合低频超声助溶
动物实验配方

IP 2% DMSO+2% Tween80+40% PEG300+water 2.4 mg/mL clear

PO 0.5% CMC-Na 16 mg/mL suspension

Tags: Dapagliflozin | BMS-512148 | 达格列嗪 | Sugar Alcohol | SGLT | AmBeed-信号通路专用抑制剂 | Dapagliflozin 纯度/质量文件 | Dapagliflozin 亚型比较 | Dapagliflozin 生物活性 | Dapagliflozin 细胞研究 | Dapagliflozin 动物研究 | Dapagliflozin 临床数据 | Dapagliflozin 参考文献 | Dapagliflozin 实验方案 | Dapagliflozin 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z